BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4145693)

  • 1. Piperonyl butoxide metabolism by cytochrome P-450: factors affecting the formation and disappearance of the metabolite-cytochrome P-450 complex.
    Franklin MR
    Xenobiotica; 1972 Nov; 2(6):517-27. PubMed ID: 4145693
    [No Abstract]   [Full Text] [Related]  

  • 2. The enzymic formation of methylenedioxyphenyl derivative exhibiting an isocyanide-like spectrum with reduced cytochrome P-450 in hepatic microsomes.
    Franklin MR
    Xenobiotica; 1971 Nov; 1(6):581-91. PubMed ID: 4154538
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of hepatic oxidative xenobiotic metabolism by piperonyl butoxide.
    Franklin MR
    Biochem Pharmacol; 1972 Dec; 21(24):3287-99. PubMed ID: 4405369
    [No Abstract]   [Full Text] [Related]  

  • 4. Response of hepatic microsomal mixed-function oxidases to various types of insecticide chemical synergists administered to mice.
    Skrinjarić-Spoljar M; Matthews HB; Engel JL; Casida JE
    Biochem Pharmacol; 1971 Jul; 20(7):1607-18. PubMed ID: 5163091
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of piperonyl butoxide concentration on the formation of cytochrome P-450 difference spectra in hepatic microsomes from mice.
    Philpot RM; Hodgson E
    Mol Pharmacol; 1972 Mar; 8(2):204-14. PubMed ID: 4402004
    [No Abstract]   [Full Text] [Related]  

  • 6. Generation of carbon monoxide during the microsomal metabolism of methylenedioxyphenyl compounds.
    Yu LS; Wilkinson CF; Anders MW
    Biochem Pharmacol; 1980 Apr; 29(8):1113-22. PubMed ID: 7387728
    [No Abstract]   [Full Text] [Related]  

  • 7. [Formation of chloroform from carbon tetrachloride in liver microsomes, lipid peroxidation and destruction of cytochrome P-450].
    Reiner O; Athanassopoulos S; Hellmer KH; Murray RE; Uehleke H
    Arch Toxikol; 1972; 29(3):219-33. PubMed ID: 4404917
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of piperonyl butoxide on cell replication and xenobiotic metabolism in the livers of CD-1 mice and F344 rats.
    Phillips JC; Price RJ; Cunninghame ME; Osimitz TG; Cockburn A; Gabriel KL; Preiss FJ; Butler WH; Lake BG
    Fundam Appl Toxicol; 1997 Jul; 38(1):64-74. PubMed ID: 9268606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation and binding of carbanions by cytochrome P-450 of liver microsomes.
    Ullrich V; Schnabel KH
    Drug Metab Dispos; 1973; 1(1):176-83. PubMed ID: 4149380
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of sulphydryl reagents on the binding and mixed function oxidation of hexobarbital in rat hepatic microsomes.
    Paul H; Illing A; Netter KJ
    Xenobiotica; 1975 Jan; 5(1):1-15. PubMed ID: 239485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The induction of hepatic cytochrome P-450 in C57 BL/10 and DBA/2 mice by isosafrole and piperonyl butoxide. A comparative study with other inducing agents.
    Fennell TR; Sweatman BC; Bridges JW
    Chem Biol Interact; 1980 Aug; 31(2):189-201. PubMed ID: 7389009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of synergists on drug metabolism.
    Hodgson E; Philpot RM; Baker RC; Mailman RB
    Drug Metab Dispos; 1973; 1(1):391-401. PubMed ID: 4149410
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of oxygenated cytochrome P-450 and of cytochrome b5 in hepatic microsomal drug oxidations.
    Baron J; Hildebrandt AG; Peterson JA; Estabrook RW
    Drug Metab Dispos; 1973; 1(1):129-38. PubMed ID: 4149374
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of a metabolite-cytochrome P-450 complex derived from the aerobic metabolism of an insect juvenile hormone analog by rat microsomal fractions.
    Mayer RT; Prough RA
    Toxicol Appl Pharmacol; 1976 Nov; 38(2):439-54. PubMed ID: 11574
    [No Abstract]   [Full Text] [Related]  

  • 15. Spectral interactions of piperonyl butoxide and isocyanides with purified hepatic cytochrome P-450 from uninduced mice.
    Beumel GA; Levi PE; Hodgson E
    Gen Pharmacol; 1985; 16(3):193-7. PubMed ID: 4018535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of purified and technical piperonyl butoxide on drug-metabolizing enzymes and ultrastructure of rat liver.
    Goldstein JA; Hickman P; Kimbrough RD
    Toxicol Appl Pharmacol; 1973 Nov; 26(3):444-58. PubMed ID: 4767580
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanism for isaxonine hepatitis. I. Metabolic activation by mouse and human cytochrome P-450.
    Lettéron P; Fouin-Fortunet H; Tinel M; Danan G; Belghiti J; Pessayre D
    J Pharmacol Exp Ther; 1984 Jun; 229(3):845-50. PubMed ID: 6547179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylenedioxyphenyl insecticide synergists as potential human health hazards.
    Franklin MR
    Environ Health Perspect; 1976 Apr; 14():29-37. PubMed ID: 789067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biphasic responses in synergistic interactions.
    Hodgson E; Ryu DY; Adams N; Levi PE
    Toxicology; 1995 Dec; 105(2-3):211-6. PubMed ID: 8571358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the synergists piperonyl butoxide and S,S,S-tributyl phosphorotrithioate on propoxur pharmacokinetics in Blattella germanica (Blattodea: Blattellidae).
    Sanchez-Arroyo H; Koehler PG; Valles SM
    J Econ Entomol; 2001 Oct; 94(5):1209-16. PubMed ID: 11681686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.